{"database": "lobbying", "table": "lobbying_activities", "rows": [[1875785, "2213be1b-ce4c-4f01-9f03-e3f145c3b960", "Q3", "MEHLMAN CONSULTING, INC.", 284950, "VALEANT PHARMACEUTICAL NORTH AMERICA LLC", 2016, "third_quarter", "LBR", "Corporate structure.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2016-10-12T15:36:35.900000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1875785"], "units": {}, "query_ms": 21.369435999076813, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}